Kane Biotech Inc. KNBIF
0.02 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.0225 Day range 0.0225
0.01038 52-week range 0.0338
- YTD
- -15.41%
- 1 year
- -22.41%
- Market cap
- 4.61M
- EPS (ttm)
- -0.01
- YTD return
- -15.41%
- 1-year return
- -22.41%
- Volume
- 10.00K
- Avg volume
- 134.59K
- Open
- 0.0225
- Previous close
- 0.0225
- Day's range
- 0.0225 – 0.0225
- 52-week range
- 0.01038 – 0.0338
2Y -0.0745 (-76.80%)
News
Kane Announces Publication of Real-World Evidence in the International Wound Journal
Kane Engages Independent Trading Group as Market Maker
Kane Biotech Signs Distribution Agreement with The Stevens Company
Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
Kane Launches New Corporate Brand and Redesigned Website
Kane Biotech Announces $250,000 Insider Loan
Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Transcript
Kane Biotech to Host Commercial Update Webcast on September 16
Kane Biotech Announces Second Quarter 2026 Financial Results
Your note
Sign in to keep a note on KNBIF — it syncs with the Stock Master app.
